Menu
Not yet recruiting NCT06035107

Contactless Radar Blood Pressure Validation

Observational Blood Pressure

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Radar blood pressure device.
Who it may be relevant to
Registry conditions: Blood Pressure. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical Validation of Contactless Radar Blood Pressure Device

Overview

The goal of this observational study is to learn how accurately blood pressure can be measured using a contactless radar device. The main questions the study aims to answer are: 1. how does blood pressure measured using radar compare with blood pressure using a cuff in patients with known high blood pressure? 2. how does blood pressure measured using radar compare with invasive blood pressure during a coronary angiogram? 3. can the radar blood pressure machine be used to measure blood pressuring during an MRI scan of the heart? 4. can the radar blood pressure machine be used to measure blood pressure during exercise? Participants in this study will have the following tests: Group 1: blood pressure measured with the radar device and a cuff when resting Group 2: blood pressure measured with the radar device and by placing a small tube inside the arteries of the wrist (during a clinical procedure) Group 3: blood pressure measured with the radar device and a cuff during a cardiac MRI scan Group 4: blood pressure measured with the radar device and a cuff during exercise

Detailed description

High blood pressure is the biggest risk factor for heart attacks and strokes. There are several machines available for measuring blood pressure, but most of them need to contact the skin causing discomfort from the inflatable cuff or risking the transmission of infections from reusing cuffs. There are also situations where the cuff machines are inaccurate, such as in older people or during exercise. Therefore, the investigators are trying to develop an accurate contactless system for measuring blood pressure.

The investigators have used advanced but safe radar to create a small machine with a camera that can measure blood pressure from a distance without the need to contact the participant's skin anywhere. It works by detecting tiny movements and changes on the skin produced from the heartbeat and pulse that cannot be seen with the human eye. The investigators want to study how accurate our radar blood pressure machine is by comparing it to other traditional methods of measuring blood pressure.

Firstly, radar blood pressure will be compared to auscultatory blood pressure (a blood pressure system using a cuff) in a group of 25 participants at rest attending a specialist blood pressure clinic. This is currently the internationally recommended method for validating new blood pressure devices.

Then radar blood pressure will be compared with invasive blood pressure (measured inside the arteries by a small tube) in 50 participants undergoing clinically-indicated cardiac catheterisation at the Royal Free Hospital.

Next a radar device capable of measuring blood pressure in participants lying inside the cardiovascular magnetic resonance (CMR) scanner will be developed. The radar blood pressure derived in the CMR scanner will be compared to oscillometric blood pressure in 25 participants (a cuff-based BP system that is currently used in patients being scanned). Finally, radar-BP will be compared with oscillometric BP in 50 participants during exercise including sit-to-stand movements and using a bike ergometer.

Interventions

  • Diagnostic test Radar blood pressure device
    The radar blood pressure device will be compared with other traditional blood pressure measurement methods.

Primary outcome measures

  • Radar blood pressure compared with blood pressure measured by manual auscultation [Time frame: 3 years]
Secondary outcome measures (1)
  • Radar blood pressure compared with blood pressure measured invasively [Time frame: 3 years]

Eligibility criteria

Inclusion criteria

Group 1:

  • Age > 18 years old
  • under the care of the complex hypertension clinic
  • able to take auscultatory blood pressure from right arm

Group 2:

  • Age >18
  • has been selected to undergo invasive coronary angiogram by a consultant cardiologist

Group 3:

  • Age >18
  • willing to undergo a cardiac MRI scan

Group 4:

\- Age > 18

Exclusion criteria

Group 1

  • anyone unable to consent
  • inaudible Korotkoff K1/K5 sounds
  • systolic BP difference >12 mmHg and/or diastolic >8 mmHg in any of the auscultatory measurements during the validation study
  • contraindication to cuff-based BP measurement e.g. lymph node clearance on right side

Group 2:

  • anyone unable to consent
  • anyone in whom right radial arterial access cannot be obtained (e.g. severe skin abnormality such as scleroderma)
  • known arterio-venous malformation or fistulas in right arm
  • any contraindication to an invasive angiogram such as severe frailty

Group 3:

  • anyone unable to consent
  • anyone with a classical contraindication to an MRI study such as known metal fragments allergy to used contrast
  • high degree heart block
  • asthma

Group 4:

  • anyone unable to consent
  • anyone with exertional chest pain or known uncontrolled angina
  • anyone with a known positive cardiac stress test.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United Kingdom · 1 center
  • UCL Bloomsbury Centre for Clinical Phenotyping — London

Identifiers

NCT: NCT06035107 · 160695 · IRAS ID: 328944

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗